Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 4,472,840 | 3,525,000 | -947,840 | $188.26M | $185.41M | 13.09% | -$2.85M |
| Nuvalent Inc | 1,855,000 | 1,375,000 | -480,000 | $131.56M | $104.91M | 7.41% | -$26.64M |
| Xenon Pharmaceuticals Inc.(XENE) | 2,325,000 | 3,025,000 | +700,000 | $78.00M | $94.68M | 6.68% | +$16.68M |
| Enliven Therapeutics Inc | 4,675,000 | 4,692,809 | +17,809 | $92.00M | $94.14M | 6.64% | +$2.13M |
| Agios Pharmaceuticals, Inc.(AGIO) | 2,185,000 | 2,325,000 | +140,000 | $64.02M | $77.33M | 5.46% | +$13.31M |
| Celldex Therapeutics, Inc.(CLDX) | 3,200,000 | 3,450,000 | +250,000 | $58.08M | $70.21M | 4.96% | +$12.13M |
| Alkermes plcSHS(ALKS) | 1,950,000 | 2,450,000 | +500,000 | $64.39M | $70.09M | 4.95% | +$5.71M |
| Viridian Therapeutics, Inc.(VRDN) | 3,600,000 | 4,875,000 | +1,275,000 | $48.53M | $68.15M | 4.81% | +$19.62M |
| Protagonist Therapeutics Inc | 0 | 1,075,000 | +1,075,000 | $0 | $59.42M | 4.19% | +$59.42M |
| Cidara Therapeutics Inc | 0 | 1,175,000 | +1,175,000 | $0 | $57.23M | 4.04% | +$57.23M |
| Scholar Rock Holding Corporation(SRRK) | 1,745,000 | 1,450,000 | -295,000 | $56.10M | $51.36M | 3.63% | -$4.74M |
| Soleno Therapeutics Inc | 1,150,000 | 610,000 | -540,000 | $82.17M | $51.11M | 3.61% | -$31.06M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 13,350,000 | +13,350,000 | $0 | $46.19M | 3.26% | +$46.19M |
| Nurix Therapeutics, Inc.(NRIX) | 3,978,907 | 3,948,653 | -30,254 | $47.27M | $44.98M | 3.17% | -$2.29M |
| Centessa Pharmaceuticals PlcADS | 2,367,578 | 3,298,289 | +930,711 | $34.05M | $43.34M | 3.06% | +$9.29M |
| Pharvaris N V COM | 1,911,433 | 1,911,433 | 0 | $30.01M | $33.64M | 2.37% | +$3.63M |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 750,000 | +750,000 | $0 | $32.73M | 2.31% | +$32.73M |
| Mind Medicine Mindmed Inc | 4,525,000 | 5,000,000 | +475,000 | $26.47M | $32.45M | 2.29% | +$5.98M |
| Spyre Therapeutics, Inc.(SYRE) | 1,988,084 | 1,988,084 | 0 | $32.08M | $29.76M | 2.10% | -$2.32M |
| Tyra Biosciences, Inc.(TYRA) | 950,000 | 3,100,000 | +2,150,000 | $8.84M | $29.67M | 2.09% | +$20.83M |
| Vera Therapeutics, Inc.CL A(VERA) | 2,561,782 | 800,000 | -1,761,782 | $61.53M | $18.85M | 1.33% | -$42.69M |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 7,692,300 | +7,692,300 | $0 | $17.46M | 1.23% | +$17.46M |
| Cogent Biosciences, Inc.(COGT) | 8,892,816 | 2,311,164 | -6,581,652 | $53.27M | $16.59M | 1.17% | -$36.67M |
| Oruka Therapeutics, Inc.(ORKA) | 1,419,714 | 1,419,714 | 0 | $14.57M | $15.91M | 1.12% | +$1.35M |
| Bright Minds Biosciences Inc.(DRUG) | 500,000 | 500,000 | 0 | $18.04M | $13.05M | 0.92% | -$4.98M |
| Apogee Therapeutics Inc | 290,000 | 290,000 | 0 | $10.83M | $12.59M | 0.89% | +$1.76M |
| Inhibikase Therapeutics, Inc.(IKT) | 5,344,432 | 5,397,488 | +53,056 | $11.70M | $10.53M | 0.74% | -$1.18M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.72M | $7.96M | 0.56% | +$240.0K |
| Tango Therapeutics, Inc.(TNGX) | 0 | 1,500,000 | +1,500,000 | $0 | $7.68M | 0.54% | +$7.68M |
| Crescent Biopharma, Inc.(CBIO) | 0 | 453,686 | +453,686 | $0 | $7.32M | 0.52% | +$7.32M |
| Neurogene Inc.(NGNE) | 925,000 | 427,866 | -497,134 | $10.83M | $6.40M | 0.45% | -$4.44M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,575,000 | 1,575,000 | 0 | $3.94M | $3.15M | 0.22% | -$787.5K |
| Avalo Therapeutics, Inc.(AVTX) | 483,000 | 483,000 | 0 | $3.87M | $2.41M | 0.17% | -$1.46M |
| Cardiff Oncology, Inc.(CRDF) | 5,384,616 | 0 | -5,384,616 | $16.91M | $0 | — | -$16.91M |
| Celcuity Inc.(CELC) | 695,650 | 0 | -695,650 | $7.03M | $0 | — | -$7.03M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 2,000,000 | 0 | -2,000,000 | $11.16M | $0 | — | -$11.16M |
| Solid Biosciences Inc | 5,825,000 | 0 | -5,825,000 | $21.55M | $0 | — | -$21.55M |
| Vaxcyte, Inc.(PCVX) | 1,650,000 | 0 | -1,650,000 | $62.30M | $0 | — | -$62.30M |